Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governments

Int J Clin Oncol. 2022 Oct;27(10):1651-1659. doi: 10.1007/s10147-022-02213-w. Epub 2022 Jul 25.

Abstract

Background: In Japan, in June 2013, The Ministry of Health, Labor and Welfare (MHLW) decided to temporarily suspend its official recommendation for the participation of girls in the national immunization program. The HPV vaccination rate in Japan soon declined to below 1%. In October 2020, the MHLW notified that the municipalities could and should begin to individually notify girls and their parents targeted for routine vaccination. We have examined how that type of individual notification has affected the number of vaccinations.

Methods: From 12 municipalities (with a combined total population of approximately 4.06 million), we collected vaccination data for all girls who attended grades 6 through 10 from April 2019 to March 2021. We analyzed the number of initial-round vaccinations that occurred by month and the timing and the subjects of the individual notifications.

Results: The annual vaccination rate for tenth-grade students in 2020 in the six municipalities that had implemented individual notification was 9.46% (342/3618), which was significantly higher than the rate of 3.22% (54/1676) in the three municipalities that had not implemented individual notification (p < 0.001). On the other hand, the annual vaccination rate for the sixth to ninth-grade students in 2020 in the six municipalities that had implemented individual notification was not significantly (p = 0.56) higher than the rate in the three municipalities that did not: 1.43% (197/13,785) versus 1.33% (83/6260), respectively.

Conclusion: This study clearly demonstrates the importance of providing information for routine vaccination directly to the targets and their parents.

Keywords: HPV vaccine; Individual notification; Japan; Local government; Suspension of recommendation.

MeSH terms

  • Female
  • Humans
  • Immunization Programs
  • Japan / epidemiology
  • Local Government
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines* / therapeutic use
  • Vaccination

Substances

  • Papillomavirus Vaccines